Teen with Down syndrome beats cancer, becomes honorary deputy

Before you go, we thought you'd like these...
Before you go close icon

An Oklahoma teen with Down syndrome, who was made an honorary deputy amid his battle with cancer, celebrated with his "fellow officers" as he was declared cancer-free.

Cade Wegener, 13, of Berryhill, was celebrated for the second time in a year by the Tulsa County Sheriff's Office when he was declared cancer free, just months after becoming an honorary deputy.

"We are happy to report that Cade has been declared cancer free," The Tulsa County Sheriff's Office wrote on Facebook. "He inspired us all with his courage and positive attitude. Congratulations Deputy Cade!"

See photos from this story:

Teen with Down Syndrome beats cancer, becomes honorary deputy
See Gallery
Teen with Down Syndrome beats cancer, becomes honorary deputy

The teen even rang their ceremonial bell, that signifies "a battle is won today," according to the plaque.

The show of solidarity comes just a year after Cade complained of a pain in his hip during gym class, KWTV reported. He was rushed to the pediatrician, and was diagnosed with a rare form of sarcoma after they found a tumor against his spine.

"Dropped a pretty big bomb on us and our family, and left us with not a whole lot of hope at that point," his dad, Chris Wegener, told KWTV.

To cheer the teen up, the Tulsa County Sheriff's Office recognized Cade as an honorary deputy of the department in April.

Sheriff Vic Regalado even presented Cade with a "Hero Among Heroes" award for his bravery and optimism in the face of cancer.

"I felt God say, 'Chris, I'm going to heal your son,'" the teen's father said to KWTV, "and that peace came over me and we've had a peace about it ever since."

To fund Cade's medical treatment, the family has since started a GoFundMe campaign.

Read Full Story

Sign up for Breaking News by AOL to get the latest breaking news alerts and updates delivered straight to your inbox.

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

People are Reading